ICADE (ICAD.PA) Stock Fundamental Analysis
EPA:ICAD - Euronext Paris - Matif - FR0000035081 - REIT - Currency: EUR
ICAD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Diversified REITs industry. ICAD may be in some trouble as it scores bad on both profitability and health. ICAD is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ICAD was profitable.
ICAD had a positive operating cash flow in the past year.
In multiple years ICAD reported negative net income over the last 5 years.
ICAD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ICAD's Return On Assets of -2.62% is on the low side compared to the rest of the industry. ICAD is outperformed by 85.00% of its industry peers.
ICAD's Return On Equity of -6.38% is on the low side compared to the rest of the industry. ICAD is outperformed by 87.50% of its industry peers.
With a Return On Invested Capital value of 1.77%, ICAD is not doing good in the industry: 82.50% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for ICAD is in line with the industry average of 3.63%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -6.38% | ||
| ROIC | 1.77% |
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
1.3 Margins
The Operating Margin of ICAD (13.47%) is worse than 87.50% of its industry peers.
ICAD's Operating Margin has declined in the last couple of years.
ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.47% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICAD is destroying value.
Compared to 1 year ago, ICAD has about the same amount of shares outstanding.
Compared to 5 years ago, ICAD has more shares outstanding
Compared to 1 year ago, ICAD has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.84, we must say that ICAD is in the distress zone and has some risk of bankruptcy.
ICAD has a Altman-Z score of 0.84. This is comparable to the rest of the industry: ICAD outperforms 42.50% of its industry peers.
The Debt to FCF ratio of ICAD is 28.49, which is on the high side as it means it would take ICAD, 28.49 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 28.49, ICAD is doing worse than 75.00% of the companies in the same industry.
ICAD has a Debt/Equity ratio of 0.99. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
ICAD's Debt to Equity ratio of 0.99 is on the low side compared to the rest of the industry. ICAD is outperformed by 77.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.99 | ||
| Debt/FCF | 28.49 | ||
| Altman-Z | 0.84 |
ROIC/WACC0.6
WACC2.94%
2.3 Liquidity
ICAD has a Current Ratio of 1.84. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ICAD (1.84) is better than 87.50% of its industry peers.
A Quick Ratio of 1.55 indicates that ICAD should not have too much problems paying its short term obligations.
ICAD's Quick ratio of 1.55 is amongst the best of the industry. ICAD outperforms 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.55 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.06% over the past year.
The Earnings Per Share has been decreasing by -9.69% on average over the past years.
The Revenue has decreased by -5.13% in the past year.
Measured over the past years, ICAD shows a small growth in Revenue. The Revenue has been growing by 0.64% on average per year.
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%
3.2 Future
Based on estimates for the next years, ICAD will show a decrease in Earnings Per Share. The EPS will decrease by -0.73% on average per year.
ICAD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.82% yearly.
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.93, which indicates a rather cheap valuation of ICAD.
Based on the Price/Earnings ratio, ICAD is valued cheaper than 87.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of ICAD to the average of the S&P500 Index (27.21), we can say ICAD is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.47, the valuation of ICAD can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 95.00% of the companies listed in the same industry.
ICAD is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.93 | ||
| Fwd PE | 6.47 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICAD indicates a somewhat cheap valuation: ICAD is cheaper than 67.50% of the companies listed in the same industry.
65.00% of the companies in the same industry are more expensive than ICAD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.04 | ||
| EV/EBITDA | 15.4 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.87%, ICAD is a good candidate for dividend investing.
ICAD's Dividend Yield is comparable with the industry average which is at 5.53.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.87% |
5.2 History
The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ICAD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-132.91%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPA:ICAD (7/1/2025, 7:00:00 PM)
21.9
-1.94 (-8.14%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners72.7%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.67B
Analysts71
Price Target25.92 (18.36%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.87% |
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-132.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.48%
PT rev (3m)-9.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.48%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.93 | ||
| Fwd PE | 6.47 | ||
| P/S | 1.06 | ||
| P/FCF | 10.04 | ||
| P/OCF | 4.56 | ||
| P/B | 0.39 | ||
| P/tB | 0.39 | ||
| EV/EBITDA | 15.4 |
EPS(TTM)3.16
EY14.43%
EPS(NY)3.39
Fwd EY15.46%
FCF(TTM)2.18
FCFY9.96%
OCF(TTM)4.81
OCFY21.95%
SpS20.62
BVpS56.72
TBVpS56.26
PEG (NY)0.97
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -6.38% | ||
| ROCE | 2.53% | ||
| ROIC | 1.77% | ||
| ROICexc | 1.97% | ||
| ROICexgc | 1.98% | ||
| OM | 13.47% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 10.57% |
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.99 | ||
| Debt/FCF | 28.49 | ||
| Debt/EBITDA | 13.44 | ||
| Cap/Depr | 187.28% | ||
| Cap/Sales | 12.74% | ||
| Interest Coverage | 2.79 | ||
| Cash Conversion | 115% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.55 | ||
| Altman-Z | 0.84 |
F-Score7
WACC2.94%
ROIC/WACC0.6
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.06%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-83.39%
EPS Next Y7.14%
EPS Next 2Y-0.27%
EPS Next 3Y-0.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.13%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-0.77%
Revenue Next Year-8.73%
Revenue Next 2Y-3.15%
Revenue Next 3Y-1.82%
Revenue Next 5YN/A
EBIT growth 1Y-17.53%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year45.89%
EBIT Next 3Y14.53%
EBIT Next 5Y8.67%
FCF growth 1Y4516.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%